Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep268 | Clinical case reports - Pituitary/Adrenal | ECE2016

Delayed diagnosis of isolated postpartum TSH deficiency: Sheehan’s syndrome or lymphocytic hypophysitis?

Iuliana Pascu , Minodora Betivoiu , Alexandra Nila , Sorina Martin , Simona Fica

Introduction: Sheehan’s syndrome (SS) is a rare complication of postpartum hemorrhage resulting in varying degrees of pituitary insufficiency. The diagnosis of SS has often been overlooked and thus delayed for many years due to its nonspecific signs and symptoms. Lymphocytic hypophysitis (LL) is also an uncommon autoimmune disorder that has to be suspected in women with recent delivery presenting with changes of one or more pituitary hormone secretions, especially when as...

ea0041ep292 | Clinical case reports - Pituitary/Adrenal | ECE2016

Congenital adrenal hyperplasia and multiple sclerosis: coincidence or not?

Betivoiu Minodora , Martin Sorina , Nila Alexandra , Pascu Iuliana , Fica Simona

Introduction: Congenital adrenal hyperplasia (CAH) is an inherited recessive disorder of adrenal steroidogenesis, generally caused by total or partial deficiency in 21-hydroxylase, due to deletions or mutations of CYP21 gene. Some studies suggest that the association between CAH and multiple sclerosis (MS) could be nonincidental: a possible MS susceptibility locus is on chromosome 6p21, on which the CYP21 gene is located.We report the c...

ea0041ep389 | Clinical case reports - Thyroid/Others | ECE2016

Graves’ orbitopathy- When the going gets tough… the tough get going?

Nila Alexandra , Betivoiu Minodora , Serbanescu Cristina , Martin Sorina , Fica Simona

Introduction: Thyroid disorders are common within the elderly population and are particularly challenging to diagnose and treat due to the presence of a wide variety of comorbidities. Graves’ ophtalmopathy remains a therapeutic predicament despite all progress made in understanding its pathogenesis, especially in the elderly population with severe presentation.Case presentation: We present the case of a 71-years-old female patient who was admitted i...

ea0041ep1015 | Thyroid (non-cancer) | ECE2016

Cardiovascular risk assessment using serum hs-CRP and Framingham risk score in newly diagnosed Graves’ disease patients

Martin Sorina , Betivoiu Minodora , Florea Suzana , Fica Simona

Introduction: In hyperthyroid patients mortality is increased by 20%, the major causes of death being cardiovascular disorders. Recent data suggest that subclinical or treated thyroid disease is associated with increased long-term vascular risk despite restoration of euthyroidism.Methods: We measured high-sensitivity C reactive protein (hs-CRP) in 116 newly diagnosed Graves’ disease (GD) patients, without prior antithyroid treatment. Levels of hs-CR...

ea0040p2 | (1) | ESEBEC2016

Methimazole induced agranulocytosis side effect-not always a bad effect: case report

Soare Iulia , Sirbu Anca , Betivoiu Minodora , Fica Simona

Background: Malignancy and hyperthyroidism used to be considered mutually exclusive, but increased association was observed. These two conditions incidence is variable, ranging between 0 and 9%, Graves’ disease is especially linked to differentiated thyroid carcinoma type.Case presentation: We report the case of a 33 year old, female, smoker, diagnosed with Basedow–Graves disease in may 2015, on methimazole 20 mg/day. She was admitted to our de...

ea0037ep652 | Pituitary: basic and neuroendocrinology | ECE2015

IGF1 deficiency in newly diagnosed Graves' disease patients

Martin Sorina , Betivoiu Minodora , Florea Suzana , Fica Simona

Introduction: Thyroid hormones influence GH/IGF1 axis, but previous studies reported discrepant results regarding serum IGF1 levels in hyperthyroidism. We have therefore investigated, at diagnosis, the relationship between serum IGF1 levels/IGF1 z scores and clinical and biological characteristics of Graves’ disease (GD) patients. We also compared IGF1 levels/IGF1 z scores, at diagnosis, between GD and autonomous hyperthyroidism patients.<p class="ab...

ea0037ep1252 | Clinical Cases–Thyroid/Other | ECE2015

Euthyroid Graves' ophthalmopathy in a patient with long-term amiodarone treatment

Betivoiu Minodora , Martin Sorina , Nila Alexandra , Fica Simona

Introduction: Ophthalmopathy, the most common extrathyroidal manifestation of Graves’ disease, occurs in 5% of cases in the absence of hyperthyroidism. Amiodarone, an iodine-rich antiarrhythmic drug, influences thyroid function, causing thyrotoxicosis or hypothyroidism, but its effect on thyroid autoimmunity is still a matter of debate.Case report: We report the case of a 58-year-old woman, suffering from non-sustained ventricular tachycardia, treat...

ea0049ep943 | Pituitary - Clinical | ECE2017

Success rates of pituitary surgery in acromegaly – a tertiary centre experience in Romania

Betivoiu Minodora , Soare Iulia , Martin Sorina , Sirbu Anca , Albu Alice , Barbu Carmen , Fica Simona

Background: Pituitary surgery is the first treatment option for acromegaly. The reported success of pituitary surgery varies between 75 and 95% for microadenomas and 45 and 68% for macroadenomas. The aim of this study was to report our experience regarding the remission rate after pituitary surgery in acromegaly patients.Methods: This retrospective study included 70 patients diagnosed with acromegaly in our clinic between 2009 and 2016. The criteria used...

ea0037ep1215 | Clinical Cases–Pituitary/Adrenal | ECE2015

‘Idiopathic'- the truly unknown or yet another hiding place for autoimmunity? A case of central diabetes insipidus in a young woman with Hashimoto thyroiditis

Nila Alexandra , Serbanescu Cristina , Epure Mihaela , Betivoiu Minodora , Martin Sorina , Fica Simona

Introduction: Central diabetes insipidus is a rare, chronic disease characterized by polyuria and polydipsia due to a partial or total vasopressin deficiency (hypothalamic – neurohypophysial system damage). The aetiology can be familial (autosomal dominant inheritance, X-linked recessive traits; mutation of the vasopressin – neurophysin II genes), secondary (tumours, infections, infiltrative diseases, trauma, vascular lesions) and idiopathic (10–30%).<p clas...

ea0049ep947 | Pituitary - Clinical | ECE2017

Long-term outcomes of medical therapy in patients with acromegaly: a retrospective analysis

Soare Iulia Simona , Betivoiu Minodora Andreea , Martin Sorina Carmen , Sirbu Anca Elena , Barbu Carmen Gabriela , Albu Alice Ioana , Fica Simona

Background: Acromegaly is a rare severe disease which, untreated, leads to increased cardiovascular and respiratory morbidity and mortality. Pituitary surgery is the first-line therapy, and medical treatment (somatostatin receptor ligands SRLs, dopamine agonists DA, and GH receptor antagonists GHRAs) is indicated for persistent disease. While selected patients are treated with DA and GHRAs, SRLs remain the mainstay of acromegaly therapy.Objective: The ai...